Bidil drug information.

Bidil drug information.

Bidil drug information BiDil may also be used for purposes not listed in this medication guide. Consumer Information Use and Disclaimer. 5 mg of hydralazine. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives. A total of 317 of these patients received BiDil for at least 6 months, and 220 received BiDil for at least 12 months. Hydralazine is believed to have both vasodilatory properties specific to the arteries and antioxidant … Jun 23, 2005 · A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). BiDil ® (isosorbide dinitrate and hydralazine hydrochloride) BiDil is a prescription medicine that is approved for use with other heart medicines to treat heart failure in black patients to improve survival, improve heart failure symptoms, and help patients stay out of the hospital longer. 3. Study participants were first asked to provide information about their demographic characteristics, their prescription patterns of BiDil over the past five years prior to participating in the study, their comfort level in taking race into account in prescribing the drug, and their beliefs about its use in the clinic. Background Since the Food and Drug Administration approved BiDil in 2005 with an indication for self-identified black patients, disagreement about the appropriateness of race-based drugs has Jun 23, 2005 · Drug Review Package.